Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
A dual GIP and GLP-1 receptor agonist that enhances insulin sensitivity, reduces appetite, and supports weight loss. Used for obesity management and type 2 diabetes control.
Tirzepatide for Weight Loss - Tirzepatide, a dual GIP/GLP-1 agonist, outperforms other weight loss drugs, with trials showing up to 20.9% weight reduction in 72 weeks. It improves insulin sensitivity and glycemic control, making it a breakthrough for obesity and diabetes
A dual GIP and GLP-1 receptor agonist that enhances insulin sensitivity, reduces appetite, and supports weight loss. Used for obesity management and type 2 diabetes control.
Tirzepatide for Weight Loss - Tirzepatide, a dual GIP/GLP-1 agonist, outperforms other weight loss drugs, with trials showing up to 20.9% weight reduction in 72 weeks. It improves insulin sensitivity and glycemic control, making it a breakthrough for obesity and diabetes